Hodder Education
SchoolsCollegesHigher EducationHealth SciencesSelf Learning
*

Drug-induced and Iatrogenic Respiratory Disease

Philippe Camus and Edward C Rosenow III


Hardback
£99.00

ISBN: 9780340809730
ISBN-10: 0340809736
Published: 29/10/2010
Extent: 364 pages


 
* *

*

Summary:
At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work, with an outstanding range of international expert contributors and two of the world's leading editors, provides an essential reference for the practising respiratory physician.

Key features:


  • The text builds upon basics with a review of basic sciences.
  • The book covers imaging, varied drug-induced interstitial lung disease including pulmonary edema and diffuse alveolar hemorrhage, acute respiratory failure, pleural involvement and upper to lower airway disease
  • A wide range of diseases are detailed from chemotherapy and radiation to biologic-induced lung disease, drug misuse, and special groups such as recipients of stem cell and solid organ transplants.
  • A range of world class contributions from key opinion leaders.

    This book provides essential information for recognizing and managing drug-induced respiratory disease for all pulmonologists and respiratory care physicians. It will be of great interest to: critical care medicine specialists, hematologists, oncologists, cardiologists, allergists, rheumatologists, neurologists, internists, blood-bank specialists, pathologists and primary care physicians.


    • Builds upon basics with a review of basic sciences
    • The book covers imaging, interstitial disease, chest symptoms and respiratory failure
    • A wide range of diseases are detailed from chemotherapy and radiation to drug misuse, the respiratory effects of neurological drugs and special groups such as pediatric drug-induced respiratory disease
    • A range of world class contributions from key opinion leaders


    Table of Contents:
    PART 1 GENERAL
    1. Classification, diagnosis and management of drug-induced respiratory disease
    2. Mechanisms of chemically induced respiratory toxicities
    3. Imaging of drug-induced lung disease
    4. Bronchoalveolar lavage in drug-induced lung disease
    5. Pathology of drug-induced respiratory disease
    6. Drug allergy in lung disease
    PART 2 - DRUG-INDUCED RESPIRATORY EMERGENCIES
    7. Drug-induced upper airway obstruction
    8. Drug-induced bronchospasm
    9. Drug-induced pulmonary oedema and acute respiratory distress syndrome
    10. Pulmonary complications of blood transfusion
    11. Drug-induced alveolar haemorrhage
    12. Pulmonary complications of illicit drug use
    13. Iatrogenic tracheobronchial and chest injury
    PART 3 - ONCOLOGY AND ALLIED CONDITIONS
    14. Pulmonary reactions to chemotherapeutic agents: The 'chemotherapy lung'
    15. Pulmonary reactions to novel chemotherapeutic agents and biomolecules
    16. Radiation-induced lung disease
    17. Pulmonary complications of bone-marrow and stem-cell transplantation
    18. Pulmonary complications of solid-organ transplantation
    19. Pulmonary infection induced by drugs
    20. Therapy-induced neoplasms
    PART 4 - NON-ONCOLOGICAL CONDITIONS
    21. Pneumonitis induced by non-cytotoxic agents
    22. Amiodarone pulmonary toxicity
    23. Eosinophilic pneumonia induced by drugs
    24. Bronchiolitis obliterans organizing pneumonia induced by drugs or radiotherapy
    25. Coughing induced by drugs
    26. Pleural disease induced by drugs
    27. Lupus erythematosus syndrome induced by drugs
    28. Vasculitis induced by drugs
    29. Pulmonary hypertension induced by drugs and toxins
    30. Respiratory involvement from herbals


    About the Author(s):
    Philippe Camus, MD
    Professor of Pulmonary Medicine, Department of Pulmonary and Critical Care Medicine, Hôpital du Bocage and Université de Bourgogne, Dijon, France

    Edward C Rosenow III, MD, MS, MACP, Master FCCP
    Emeritus Professor of Medicine, Former Chair Division of Pulmonary and Critical Care Medicine, Mayo Distinguished Clinician, Mayo Clinic School of Medicine, Rochester, Minnesota, USA


    Contributors:
    Lucien Abenhaim, LARISK Consultants, School of Hygiene and Tropical Medicine, London, UK; Bekele Afessa, Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA; James N Allen, Division of Pulmonary and Critical Care Medicine, Ohio State University, Columbus, OH, USA; Noreen Aziz, Rubin Center for Cancer Survivorship, James P Wilmot Cancer, Center, University of Rochester Medical Center, Rochester, NY, USA; K Suresh Babu, Infection, Inflammation and Repair, Southampton General Hospital, Southampton, UK; Andrew D Badley, Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA; Francesco Bonella, Ruhrlandklinik, Department of Pneumology/Allergy, Essen, Germany; Kim Bouillon, Department of Epidemiology and Public H


    Readership:
    Respiratory physicians, pharmacologists


    * *
    		*
    Your order basket is currently empty.